Mesco Pharmaceuticals: Board Meeting Outcome for Outcome Of Board Meeting Dated 14Th February 2022

Board Meeting the Board of Directors of the Company has considered and approved the following items along with other items at their meeting held today on February 14 2021: i. Unaudited Financial Results for the quarter and nine months ended December 31 2021; andii. Limited Review Report given by the Statutory Auditor of the Company for the quarter and nine months ended December 31 2021 ;